Interleukin-6 and C-reactive protein levels and 9-year cognitive decline in community-dwelling older women: The women's health and aging study II

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 7, 2015, Pages 873-878

  Palta, Priya ^a,b   Xue, Qian Li ^c   Deal, Jennifer A ^a   Fried, Linda P ^d   Walston, Jeremy D ^c   Carlson, Michelle C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Medicine   (United States)

Author keywords

C reactive protein; Cognitive decline; Interleukin 6; Psychomotor speed

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

AGED; AGING; BLOOD; COGNITIVE DEFECT; COHORT ANALYSIS; EXECUTIVE FUNCTION; FEMALE; HUMAN; MEMORY; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; TIME;

AGED; AGING; C-REACTIVE PROTEIN; COGNITION DISORDERS; COHORT STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; INTERLEUKIN-6; MEMORY; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 84936759291     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu132     Document Type: Article

References (30)

1. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002; 52: 168-174
2. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol. 2004; 61: 668-672
3. Sundelof J, Kilander L, Helmersson J, et al. Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. J Alzheim Dis. 2009; 18: 79-87. doi: 10.3233/JAD-2009-1126
4. Ravaglia G, Forti P, Maioli F, et al. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol Aging. 2007; 28: 1810-1820
5. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005; 64: 1371-1377
6. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002; 59: 371-378
7. Carlson MC, Fried LP, Xue QL, Bandeen-Roche K, Zeger SL, Brandt J. Association between executive attention and physical functional performance in community-dwelling older women. J Gerontol B Psychol Sci Soc Sci. 1999; 54: S262-S270
8. Folstein MF, Folstein SE, McHugh PR. Minimental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198
9. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institutes of Health, National Institute on Aging; 1995
10. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991; 5: 125-142
11. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958; 8: 271-276
12. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982; 17: 37-49
13. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61: 76-80
14. Carlson MC, Xue QL, Zhou J, Fried LP. Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2009; 64: 110-117. doi: 10.1093/gerona/gln008
15. Lyketsos CG, Toone L, Tschanz J, et al. Population-based study of medical comorbidity in early dementia and cognitive impairment, no dementia (CIND): association with functional and cognitive impairment. The Cache County Study. Am J Geriatr Psychiatr.2005; 13: 656-664
16. Rosano C, Chang YF, Kuller LH, et al. Long-term survival in adults 65 years and older with white matter hyperintensity: association with performance on the digit symbol substitution test. Psychosom Med. 2013; 75: 624-631. doi: 10.1097/PSY.0b013e31829c1df2
17. Rosano C, Brach J, Studenski S, Longstreth WT Jr, Newman AB. Gait variability is associated with subclinical brain vascular abnormalities in highfunctioning older adults. Neuroepidemiology. 2007; 29: 193-200
18. Nadkarni NK, Nunley KA, Aizenstein H, et al.; Health ABC Study. Association between cerebellar gray matter volumes, gait speed, and information-processing ability in older adults enrolled in the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2014; 69: 996-1003. doi: 10.1093/gerona/glt151
19. Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R. Cortical grey matter demyelination can be induced by elevated proinflammatory cytokines in the subarachnoid space of MOG-immunized rats. Brain. 2013; 136(Pt 12): 3596-3608. doi: 10.1093/brain/awt279
20. Mielke MM, Xue QL, Zhou J, Chaves PH, Fried LP, Carlson MC Baseline serum cholesterol is selectively associated with motor speed and not rates of cognitive decline: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2008; 63: 619-624
21. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004; 292: 2237-2242
22. Morrow DA. Cardiovascular Biomarkers: Pathophysiology and Disease Management. Totowa, NJ: Humana Press; 2006
23. Jenny NS, French B, Arnold AM, et al. Long-term assessment of inflammation and healthy aging in late life: the cardiovascular health study all stars. J Gerontol A Biol Sci Med Sci. 2012; 67: 970-976. doi: 10.1093/gerona/glr261
24. St-Pierre AC, Cantin B, Bergeron J, et al. Inflammatory markers and longterm risk of ischemic heart disease in men A 13-year follow-up of the Quebec cardiovascular study. Atherosclerosis. 2005; 182: 315-321
25. Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013; 36: 166-175. doi: 10.2337/dc12-0702
26. Barrientos RM, Frank MG, Watkins LR, Maier SF. Memory impairments in healthy aging: role of aging-induced microglial sensitization. Aging Dis. 2010; 1: 212-231
27. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr SoC 1999; 47: 639-646
28. Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011; 97: 1054-1060. doi: 10.1136/hrt.2011.224857
29. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011; 42: 722-727. doi: 10.1161/STROKEAHA.110.595082
30. Aggarwal NT, Schneider JA, Wilson RS, Beck TL, Evans DA, Carli CD. Characteristics of MR infarcts associated with dementia and cognitive function in the elderly. Neuroepidemiology. 2012; 38: 41-47. doi: 10.1159/000334438